News archive

The magazine Medicine Maker has voted for Claus-Michael Lehr, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of the Saarland as one of the hundred most influential experts in the field of drug development.

88. ZEBET Seminar in Berlin

Thursday, 21 May 2015 11:57

Dr. Sabine Richter from the TU Dresden will talk about her development of a fish embryo reproductive toxicity test (FERT).

Most of the strategies for the preparation of antibodies are still based on the immunization of humanized mouse models. To replace this procedure, there are several methods, for instance, the phage display. French researchers now have turned to another method: they improved the ability of immunization of blood cells in vitro.

Lush Prize 2015: Nominations open

Monday, 27 April 2015 13:09

Now in its fourth year, The Lush Prize supports animal-free testing in order to reach the breakthrough according to the strategy "Toxicology in the 21th Century".

A Dresden scientist has been awarded the Novartis Pharma "EYEnovative sponsorship prize" for his development of a human in vitro retina model. It is an organoid, which has been developed from induced pluripotent stem cells.

A Dresden scientist has been awarded with the "EYEnovative Award" from Novartis Pharma GmbH for his development of an in vitro model of a human retina. The model consists of an organoid, which has been prepared from induced pluripotent stem cells.

The plans of the European Commission to cut the European research program "Horizon 2020" by around 2.7 billion euros have been interrupted. On 20th of April, the budgetary and the economic committee as well as the transport and industry committee have voted against the proposed reduction of the European Research Framework Programme "Horizon 2020".

Young Scientist Travel Awards (YSTA)

Tuesday, 21 April 2015 13:28

To promote sustainability of the 3R principles of Russel & Burch into Science of the 21st Century, EUSAAT wants to support the participation of as many young scientists as possible from different countries in the EUSAAT 2015 Congress by providing a special financial support.

This year, the young scientist Dr. Thomas Wollert, group leader at the Max Planck Institute of Biochemistry in Martinsried near Munich, Germany, receives the Eppendorf Young Investigator Award for his elucidation of the cellular mechanism of autophagy. The prize is worth 20,000 euros.

The Fund for the Replacement on Animals in Medical Experiments (FRAME) is conducting an online survey by the question of what is needed to advance the termination of animal experiments. Each is addressed to participate in the survey.